- Home
- ADBE vs PFE Comparison
ADBE vs PFE Comparison
Compare ADBE & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADBE | PFE |
|---|---|---|
| Founded | 1982 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.0B | 141.6B |
| IPO Year | 1986 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADBE | PFE |
|---|---|---|
| Price | $334.24 | $25.15 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 23 | 10 |
| Target Price | ★ $428.95 | $27.40 |
| AVG Volume (30 Days) | 4.4M | ★ 46.9M |
| Earning Date | 12-10-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 6.91% |
| EPS Growth | 35.11 | ★ 131.89 |
| EPS | ★ 16.70 | 1.73 |
| Revenue | $23,769,000,000.00 | ★ $62,785,000,000.00 |
| Revenue This Year | $11.70 | N/A |
| Revenue Next Year | $9.21 | N/A |
| P/E Ratio | $20.96 | ★ $14.42 |
| Revenue Growth | ★ 10.53 | 3.89 |
| 52 Week Low | $311.59 | $20.92 |
| 52 Week High | $465.70 | $27.69 |
Technical Indicators
Market Signals| Indicator | ADBE | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 40.22 | 48.32 |
| Support Level | $350.58 | $24.83 |
| Resistance Level | $356.68 | $25.20 |
| Average True Range (ATR) | 8.04 | 0.44 |
| MACD | -1.59 | -0.06 |
| Stochastic Oscillator | 8.37 | 17.58 |
Price Performance
Historical ComparisonAbout ADBE Adobe Inc.
Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing, and engaging with compelling content multiple operating systems, devices, and media. The company operates with three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.